Qoolabs, Inc.
Qoolabs is a biotech company dedicated to providing innovative antibody products for research, diagnostics, and therapeutic drug development. Founded in 2012, it specializes in the QMAb™ platform technology for rapid and high-quality monoclonal antibody discovery from blood, offering services and products including rabbit monoclonal antibodies, lateral flow rapid tests, proteins, reagents, and assay kits. The company emphasizes high specificity, affinity, and stability in its antibody development and production processes, serving clients worldwide with a focus on advancing scientific research and medical diagnostics.
Industries
Nr. of Employees
small (1-50)
Products
Catalog of rabbit monoclonal antibodies
Off-the-shelf rabbit-derived monoclonal antibodies covering targets such as viral antigens (HCV core, HBV core, SARS-CoV-2 N and S) and species-specific immune proteins (e.g., guinea pig cytokines).
Lateral flow rapid tests for epitope tags and proteins
Rapid test strips for visual detection of tagged recombinant proteins and common epitope tags with associated positive-control proteins.
Recombinant proteins and positive-control reagents
Supply of recombinant antigens and positive-control proteins (epitope tags, viral antigens, cytokines) for assay development and validation.
Reagents and assay kits (antigen assay buffers, ELISA kits)
Pre-formulated reagents and assay kits for antigen detection and sample treatment used in immunoassays.
Catalog of rabbit monoclonal antibodies
Off-the-shelf rabbit-derived monoclonal antibodies covering targets such as viral antigens (HCV core, HBV core, SARS-CoV-2 N and S) and species-specific immune proteins (e.g., guinea pig cytokines).
Lateral flow rapid tests for epitope tags and proteins
Rapid test strips for visual detection of tagged recombinant proteins and common epitope tags with associated positive-control proteins.
Recombinant proteins and positive-control reagents
Supply of recombinant antigens and positive-control proteins (epitope tags, viral antigens, cytokines) for assay development and validation.
Reagents and assay kits (antigen assay buffers, ELISA kits)
Pre-formulated reagents and assay kits for antigen detection and sample treatment used in immunoassays.
Services
End-to-end service accepting customer antigens to produce cloned, validated monoclonal antibodies derived from peripheral blood B cells, including sequencing of paired heavy/light chains and recombinant expression.
Production of recombinant antibodies in mammalian cells with scalability from research quantities to gram-scale and options for custom testing and multi-validation.
Engineering workflows including affinity maturation, humanization, and stable cell line generation to optimize antibodies for downstream use.
Design and supply of lateral flow assays for rapid detection of proteins and common epitope tags, plus positive-control proteins.
Development and validation of immunoassays (ELISA, lateral flow) and functional testing (neutralization, ELISpot, Western blot) for research and diagnostic use.
End-to-end service accepting customer antigens to produce cloned, validated monoclonal antibodies derived from peripheral blood B cells, including sequencing of paired heavy/light chains and recombinant expression.
Production of recombinant antibodies in mammalian cells with scalability from research quantities to gram-scale and options for custom testing and multi-validation.
Engineering workflows including affinity maturation, humanization, and stable cell line generation to optimize antibodies for downstream use.
Design and supply of lateral flow assays for rapid detection of proteins and common epitope tags, plus positive-control proteins.
Development and validation of immunoassays (ELISA, lateral flow) and functional testing (neutralization, ELISpot, Western blot) for research and diagnostic use.
Expertise Areas
- Monoclonal antibody discovery from peripheral blood
- Recombinant antibody expression and scale-up
- Antibody engineering and affinity optimization
- Lateral flow rapid-test development
Key Technologies
- Single-cell B-cell cloning and paired heavy/light-chain sequencing
- Mammalian cell recombinant expression
- Epitope mapping
- Lateral flow immunoassays
News & Updates
Participate in the AACR 2025 event, access flyers and catalogs, and discover new antibody products.
SBIR Grants and Contracts from NIH and CDC
Qoolabs has received multiple SBIR grants and contracts from NIH and CDC, supporting its research and development in antibody technology.
Participate in the AACR 2025 event, access flyers and catalogs, and discover new antibody products.
SBIR Grants and Contracts from NIH and CDC
Qoolabs has received multiple SBIR grants and contracts from NIH and CDC, supporting its research and development in antibody technology.